THE 5 PRs THAT WILL PROPEL THE PPS TO $1
Below are the five press releases that will ignite the BIEL breakout and drive the PPS toward the long awaited $1 milestone. Each PR builds on the previous one, creating a compounding momentum cycle that the market cannot ignore.
PR #1 — BIEL’s AI Pivot + ActiPatch’s Zero Cost Deployment + Stock as an AI Vehicle
This is the visibility catalyst.
BIEL’s ActiPatch is already market ready, already FDA cleared, and requires no development or startup cost for partners. That alone puts BIEL in a different category from early stage med tech companies that burn millions before revenue.
But the real spark is the AI pivot.
ActiPatch becomes the hardware layer for AI driven bioelectronic pain therapy — the physical delivery system for Electrome’s AI platform. This is the same “AI + hardware” convergence that sent other companies soaring.
And unlike private AI health startups, BIEL is publicly traded, giving anyone a direct, accessible vehicle to participate in the AI frenzy.
This PR introduces:
• BIEL’s role in the AI healthcare ecosystem
• ActiPatch as the ready to deploy hardware platform
• Zero R&D cost, zero regulatory lag, zero product development delay
• BIEL stock as the public gateway to the AI bioelectronic revolution
This is the PR that wakes up the market.
PR #2 — BIEL Confirms Profitability Path as Revenues Accelerate
This is the credibility catalyst.
BIEL announces that rising ActiPatch demand, expanding distribution, and new partnerships are pushing the company toward near term profitability.
Key points:
• Revenue growth quarter over quarter
• Expanding U.S. and international distribution
• Increasing reorder volume
• Lower manufacturing cost per unit
• Clear timeline to profitability
This PR signals to the market that BIEL is no longer a speculative story — it’s a scaling business with real revenue traction.
PR #3 — BIEL Financials Becoming Current + Quarterly Reporting Returns
This is the institutional catalyst.
BIEL announces that it is bringing its financials current, audited and will report quarterly going forward.
This unlocks:
• Global liquidity
• Access to new investors
• Eligibility for uplisting pathways
• Institutional visibility
• Analyst coverage potential
This PR removes the final barrier preventing large money from entering the stock.
PR #4 — Strategic Partners Accumulate BIEL Stock for Their Modern Treasury Reserve to Capture the Expected Valuation Premium
This is the validation catalyst.
BIEL announces that strategic partners — including those integrating ActiPatch into AI driven platforms — are accumulating BIEL shares as part of their Modern Treasury Reserve strategy.
Partners are purchasing BIEL stock because they expect BIEL’s PPS growth to deliver a valuation premium to their treasury holdings.
This confirms:
• Partners see BIEL as an appreciating asset
• They expect BIEL’s PPS to rise significantly as the AI bioelectronic ecosystem scales
• They want their treasury to benefit from that upside
• They are aligning themselves financially with BIEL’s long term success
This PR tells the market that the people closest to the technology — the ones who know the real numbers, the real demand, and the real roadmap — are buying BIEL stock not just for alignment, but for treasury growth.
Nothing validates a company more than partners betting their treasury on its future valuation.
PR #5 — BIEL Announces Stock Buyback Program After Loans Are Paid Off
This is the valuation catalyst.
Once loans are paid off, BIEL announces a share buyback program — a powerful signal of confidence and a direct mechanism to increase shareholder value.
A buyback:
• Reduces the float
• Increases EPS
• Strengthens price stability
• Attracts long term investors
• Demonstrates financial discipline
This is the PR that transforms BIEL from a turnaround story into a high growth, shareholder focused company.
THE COMPOUNDING EFFECT
Each PR builds on the previous one:
1. Visibility — AI pivot + zero cost ActiPatch + stock as AI vehicle
2. Credibility — profitability approaching
3. Legitimacy — audited financials + quarterly reporting
4. Validation — partners buying BIEL stock for treasury growth and valuation premium
5. Valuation Power — stock buyback program
This sequence is how a sub penny stock becomes a story stock, then a momentum stock, then a fundamental growth stock, and finally a $1+ stock.
Below are the five press releases that will ignite the BIEL breakout and drive the PPS toward the long awaited $1 milestone. Each PR builds on the previous one, creating a compounding momentum cycle that the market cannot ignore.
PR #1 — BIEL’s AI Pivot + ActiPatch’s Zero Cost Deployment + Stock as an AI Vehicle
This is the visibility catalyst.
BIEL’s ActiPatch is already market ready, already FDA cleared, and requires no development or startup cost for partners. That alone puts BIEL in a different category from early stage med tech companies that burn millions before revenue.
But the real spark is the AI pivot.
ActiPatch becomes the hardware layer for AI driven bioelectronic pain therapy — the physical delivery system for Electrome’s AI platform. This is the same “AI + hardware” convergence that sent other companies soaring.
And unlike private AI health startups, BIEL is publicly traded, giving anyone a direct, accessible vehicle to participate in the AI frenzy.
This PR introduces:
• BIEL’s role in the AI healthcare ecosystem
• ActiPatch as the ready to deploy hardware platform
• Zero R&D cost, zero regulatory lag, zero product development delay
• BIEL stock as the public gateway to the AI bioelectronic revolution
This is the PR that wakes up the market.
PR #2 — BIEL Confirms Profitability Path as Revenues Accelerate
This is the credibility catalyst.
BIEL announces that rising ActiPatch demand, expanding distribution, and new partnerships are pushing the company toward near term profitability.
Key points:
• Revenue growth quarter over quarter
• Expanding U.S. and international distribution
• Increasing reorder volume
• Lower manufacturing cost per unit
• Clear timeline to profitability
This PR signals to the market that BIEL is no longer a speculative story — it’s a scaling business with real revenue traction.
PR #3 — BIEL Financials Becoming Current + Quarterly Reporting Returns
This is the institutional catalyst.
BIEL announces that it is bringing its financials current, audited and will report quarterly going forward.
This unlocks:
• Global liquidity
• Access to new investors
• Eligibility for uplisting pathways
• Institutional visibility
• Analyst coverage potential
This PR removes the final barrier preventing large money from entering the stock.
PR #4 — Strategic Partners Accumulate BIEL Stock for Their Modern Treasury Reserve to Capture the Expected Valuation Premium
This is the validation catalyst.
BIEL announces that strategic partners — including those integrating ActiPatch into AI driven platforms — are accumulating BIEL shares as part of their Modern Treasury Reserve strategy.
Partners are purchasing BIEL stock because they expect BIEL’s PPS growth to deliver a valuation premium to their treasury holdings.
This confirms:
• Partners see BIEL as an appreciating asset
• They expect BIEL’s PPS to rise significantly as the AI bioelectronic ecosystem scales
• They want their treasury to benefit from that upside
• They are aligning themselves financially with BIEL’s long term success
This PR tells the market that the people closest to the technology — the ones who know the real numbers, the real demand, and the real roadmap — are buying BIEL stock not just for alignment, but for treasury growth.
Nothing validates a company more than partners betting their treasury on its future valuation.
PR #5 — BIEL Announces Stock Buyback Program After Loans Are Paid Off
This is the valuation catalyst.
Once loans are paid off, BIEL announces a share buyback program — a powerful signal of confidence and a direct mechanism to increase shareholder value.
A buyback:
• Reduces the float
• Increases EPS
• Strengthens price stability
• Attracts long term investors
• Demonstrates financial discipline
This is the PR that transforms BIEL from a turnaround story into a high growth, shareholder focused company.
THE COMPOUNDING EFFECT
Each PR builds on the previous one:
1. Visibility — AI pivot + zero cost ActiPatch + stock as AI vehicle
2. Credibility — profitability approaching
3. Legitimacy — audited financials + quarterly reporting
4. Validation — partners buying BIEL stock for treasury growth and valuation premium
5. Valuation Power — stock buyback program
This sequence is how a sub penny stock becomes a story stock, then a momentum stock, then a fundamental growth stock, and finally a $1+ stock.
